Tuesday, December 18, 2018, the annual Future Healthcare 100 Forum will be held atRenaissance Beijing Chaoyang HotelHeld as the annual flagship event for discussions on trends in the healthcare industry, the forum features“Tide IN”as the theme, exploring the development trends of the healthcare industry in the coming year from the perspectives of policy direction, technological evolution, business models, industrial collaboration, and capital flows.
In this golden age, you will witness how some intriguing minds are earnestly contemplating the direction of the tide. At the 2018 Future Healthcare 100 Forum, meet these individuals—and become one of them.
The following are152ndGuestSorted by agenda time, given the extensive lineup,Full reading takes 8 minutes, providing you with aQuickly find the guest list, speech topics, and speech times, click the link:http://c7.gg/bwhxp,Quick RegistrationPlease click the image below.
12 Thematic Forums Focusing on the Top 10 Most Watched Areas in 2018
Conference Highlights:
1. Examine social transformation, economic fluctuations, and consumption evolution from the perspective of China and the world at large, adopting a broad viewpoint to identify the direction of change in the healthcare industry.
2. Technology is the primary driving force behind industrial development. Starting with the most closely watched technological applications of 2018—artificial intelligence, big data, surgical robots, gene sequencing, and the Internet of Things (IoT)—this section provides an in-depth analysis of how these technologies will reshape the landscape of the healthcare industry.
3. Internet healthcare and specialized chain medical service providers are flourishing across the country,Innovation from the Edge Has Delivered a Major Shock to the Core of the Industry: How Should Hospital Administrators and Corporate Practitioners Understand New Innovation Trends?
4. The pharmaceutical, medical device, and distribution sectors have long been hubs for listed companies in the healthcare industry, with commercial insurance serving as a critical component of their business models. How are these players strategizing their positioning in the face of emerging technologies?
| Time | Subject | Guest | |
| December 18 AM | Host: Bi Yuanfeng | Co-founder and COO of VCBeat | ||
| 9:00-9:30 | The Macro Backdrop of China's Industrial Innovation in the Post-Globalization Era | Kang Yong | Chief Economist, KPMG China | |
| 9:30-10:00 | New Landscape, New Momentum: Outlook for Macroeconomy and Asset Allocation in 2019 | Chen Chao | Deputy Dean, China Investment Corporation Research Institute | |
| 10:00-10:30 | Reconstructing China’s New Five-Year Consumer Psychology and the Migration Trajectory of Physician Group Consciousness | Zhang Zhiying | Medical Science Popularizer, Cardiologist | |
| 10:30-11:00 | The Belt and Road Initiative: Opportunities and Challenges in the Research and Development of Traditional Chinese Medicinal Plants | Dou Jinhui | Former Director of Botanical Drug Review, U.S. FDA; Deputy Dean of Shijiazhuang Yiling Pharmaceutical Research Institute | |
| 11:00-11:30 | Perception, Computation, and Living Organisms: Three Keywords for the Endgame of Investment | Liu Wei | CEO, BV Baidu Ventures | |
| 11:30-12:00 | Trending ING—The Relativity of Evolution in the Innovative Healthcare Industry, 2018 | Li Datao | Founder of VCBeat | |
| December 18 PM | Moderator: Liu Hui | CIO, VCBeat | ||
| 14:00-14:20 | The Role of Artificial Intelligence in Visual Computing and Medicine | Demetri Terzopoulos | Chief Scientist at VoxelTech, Fellow of the Royal Society, Fellow of the Canadian Academy of Sciences, and Fellow of the Institute of Electrical and Electronics Engineers (IEEE) | |
| 14:20-14:40 | The Development and Prospects of Future Surgical Robots | Wang Tianmiao | Professor at Beihang University, Honorary Director of the Institute of Robotics | |
| 14:40-15:00 | Big Data/Cloud Computing: A Cloud Narrative Built on a Data Foundation (Draft) | Chen Si | Head of Medopad Asia-Pacific | |
| 15:00-15:20 | Disruptive Innovations in Gastrointestinal Disease Screening | Ji Pengsong | Former Associate Professor at Tsinghua University, Chairman of Anhan Medical | |
| 15:20-15:40 | Prospects for the Application of NGS Technology in Pharmacogenomics | Hu Songnian | Director of the Key Laboratory of Genomic Sciences and Information, Chinese Academy of Sciences; Professor at Zhejiang University | |
| 15:40-16:00 | The Next Frontier in the Gene Sequencing Industry | Zhou Daixing | CEO of Berry Genomics | |
| 16:00-16:20 | AWS Cloud Superpowers Boost the Development of the Healthcare Industry | Shi Fei | AWS Solutions Architect | |
| 16:20-16:40 | Standard System and Progress in the Internet of Medical Things (IoMT) | Zhang Bin | Deputy Director of Wuxi Medical IoT Research Institute | |
| 16:40-17:00 | A Brief Discussion on the Application and Prospects of Artificial Intelligence in Digital Pathology | Yang Lin | Chairman of Dijinga | |
| December 19 AM | Host: Liu Hui | CIO, VCBeat | ||
| 9:00-9:25 | Hospital Innovation Thinking: From the Inside Out | Xiang Peng | Vice President, Jiande First People's Hospital | |
| 9:25-9:50 | Practices and Reflections on Online Medical Consultation | Wang Hang | President of the Yinchuan Internet + Medical Health Association | |
| 9:50-10:10 | Transformation of Service Models in the Context of New Technologies | Li Tiantian | Founder and Chairman of DXY | |
| 10:10-10:30 | The Path of Cost Shifting—Third-Party Medical Services in a Parallel Universe | Jiang Ying | General Manager, Ping An Health (Diagnostic) Center | |
| 10:30-10:50 | Connecting + AI: Empowering the Tripartite Coordination of Healthcare, Medical Insurance, and Pharmaceuticals (Proposed) | Li Zhaozi | General Manager, Strategic Marketing Department, WeDoctor | |
| 10:50-11:10 | Exploration and Practice of Specialized Chain Medical Service Institutions | Shao Zongzong | CEO of Malong Dental China | |
| 11:00-11:30 | How to Break the “Connected but Not Locked” Dilemma: What Should Clinics Lock In? | He Haiyang | Founder and CEO of Johnson Medical | |
| 11:30-11:50 | Cutting Through the Fog: Exploring the Underlying Simple Business Logic Behind Innovative Models | Lu Gang | Partner, Legend Star | |
| December 19 PM | Moderator: Bi Yuanfeng | Co-founder and COO of VCBeat | ||
| 14:00-14:20 | Leveraging Theranostics to Address the Challenges of Pharmaceutical Transformation | Liu Qian | Pharmaceutical Writer, Vice President of AstraZeneca China Region | |
| 14:20-14:40 | From Hardware to Connectivity to Services: The Transformation and Upgrading Path of Home Medical Devices | Liu Yi | Chairman of Andon Health | |
| 14:40-15:00 | The Path of Innovative Transformation of Jointown’s B2B Platform (Draft) | Wan Yougang | General Manager, FBBC Terminal Business Division, Jointown Health 998 E-commerce Group | |
| 15:00-15:20 | Technology-Driven Innovations in Insurance and Health Management | Zheng Yi | Deputy General Manager and Chief Medical Officer, Ping An Medical Insurance | |
| 15:20-15:40 | Investment in the Big Health Industry in the New Era | Zhang Leidi | Managing Director, Equity Investment, China Life Insurance | |
| 15:40-16:00 | The Barbarian's Guide to Philips' Innovation | Zeng Yongqin, Senior Director, Philips HealthTech Innovation Lab | |
| 16:00-16:20 | Ping An Insurance’s Investment Logic in Healthcare | Zhang Jiang | Managing Partner, Ping An Capital | |
| 16:20-16:40 | The New Landscape and Future of Pharmaceutical Distribution | Wang Letian | General Manager of Sinopharm Online | |
Conference Highlights:VCBeat·VBInsight’s “China Internet Hospital Report 3.0” is officially released. Through in-depth interviews with Yinchuan Smart Internet Hospital, Wuzhen Internet Hospital, 39 Internet Hospital, and the First Affiliated Hospital of Zhejiang University School of Medicine Internet Hospital, as well as surveys and analyses of physicians on internet hospital platforms, this report clarifies regulatory policies, stakeholder perspectives, and key considerations for practical implementation. It summarizes operational achievements and best practices, providing readers with a practical guide to operating internet hospitals.
| Time | Subject | Guest |
| Moderator: Song Longtao | Partner at Huimei Capital | ||
| 9:00-9:20 | "AI + Clinical Practice: The 'Xuanwu Model' in the Era of Smart Healthcare" | Liang Zhigang | Director, Information Center, Xuanwu Hospital |
| 9:20-9:40 | User-Centric: Building a New Ecosystem for “Internet + Smart Healthcare” | Zeng Boyi | Co-founder of Chunyu Doctors |
| 9:40-10:00 | Internet + Smart Hospital: Building an Internet Service Bus for Internal and External Hospital Operations | Wei Jianfeng | President of Zhuojian Technology |
| 10:00-10:20 | Deconstructing the New Model of Health Services in the Era of Consumption Upgrading | Cong Lulu | Chief User Growth Officer, DXY |
| 10:20-10:40 | Internet Hospitals: The Endgame and Potential for Growth | Jiang Tianjiao | Director, Industrial Finance Department, Founder Securities |
| 10:40-11:00 | Industry Insights: “Internet Hospital Report” Released | Luo Shiming | Senior Researcher, VCBeat |
| 11:00-12:00 | Focus Roundtable: Expectations and Challenges of Internet Hospitals | Moderator: Luo Xi | Head of Healthcare, CITIC Securities |
| Zhang Qi | CEO of Huimei Technology | ||
| Cong Lulu | Chief User Growth Officer, DXY | ||
| Yao Feng'e | KPMG Healthcare Industry Lead Partner | ||
| Wei Jianfeng | President, Zhuojian Technology | ||
Conference Highlights:By comprehensively analyzing practical cases of “pharmaceutical e-commerce + insurance,” “internet healthcare + insurance,” and process control and precise cost containment enabled by internet technologies, this article examines how technologies such as blockchain, cloud computing, big data, and artificial intelligence empower the insurance industry. What industrial landscape and technological system will emerge in the future?
| Time | Subject | Guest |
| Host: Wang Huizhe | Co-founder of Doubao.com | ||
| 14:00-14:20 | Strengthening the Medical Insurance System to Drive Innovation in the Health Industry | Hao Chunpeng | Deputy Secretary-General of the China Health Insurance Research Association, President of China Health Insurance Magazine |
| 14:20-14:40 | Innovation Trends in Commercial Health Insurance in the Asia-Pacific Region and China | Liu Chang | Director, Asia-Pacific Region, iShouKang |
| 14:40-15:00 | Building an HMO with Chinese Characteristics Through Fintech | Wu Yiyu | Deputy General Manager, ZhongAn Technology |
| 15:00-15:30 | PBM Localization: Boosting the Development of Health Insurance | Shi Mengmeng | General Manager, Medtronic China |
| 15:30-15:50 | Customization of Insurance Products Based on Big Data Analytics and Artificial Intelligence | Yang Zhe | CEO of Daxiang Insurance |
| 15:50-16:10 | Technology-Driven Innovation in Healthcare Payments | Huo Lilong | Chairman of Jindou Data |
| 16:10-17:00 | Focus Roundtable: Where Does Commercial Health Insurance Fit in the Multi-Layered Healthcare Security System? | Moderator: Ren Bobing | Vice President of Investment, Baidu Ventures |
| Zhou Tao | CTO of Yibao Health | ||
| Cheng Hong | Co-founder, Zhisuan Health | ||
| Liu Yang | Founder, Molecular Laboratory | ||
| Ma Yukun | CEO of Yuguo Doctor | ||
| Zhang Shengming | Founder and CEO of Jianyibao | ||
Conference Highlights:Centered on the industrial division of labor encompassing “basic R&D, technology translation, and market application,” guests from diverse fields—including sequencing technologies, clinical and health application innovation, gene editing, and tumor detection—will share in-depth insights into their research findings and achievements in translational applications.
| Time | Subject | Guest |
| Moderator: Chen Bing | Partner, Honghui Capital | ||
| 14:00-14:20 | Advances in Single-Cell Sequencing of Circulating Tumor Cells and Their Significance | Wang Jiejun | Expert Committee Member for New Drug Review, National Medical Products Administration |
| 14:20-14:40 | Path Selection for the Industrialization of NGS-Based Early Cancer Diagnosis | Zhou Jun | CEO of Huirui Gene |
| 14:40-15:00 | Advances in Tumor Immunotherapy and Reflections from Clinicians | Cai Xiuyu | Associate Professor, Sun Yat-sen University Cancer Center |
| 15:00-15:30 | Additive Manufacturing: The Future of Personalized Precision Surgery | Zhao Xiaowen | Chairman and Researcher of AccelLab |
| 15:30-15:50 | Insights from the Overseas Precision Oncology Industry | Luo Xi | Head of the Healthcare Team, CITIC Securities |
| 15:50-16:10 | The Path to Precision in Immunotherapy for Oncology | Jin Ge | CEO, Rendong Medicine |
| 16:10-16:30 | History and Trends of the Biopharmaceutical Industry: The Formation of Highly Specialized Segments | Luo Shun | Founder and President of Jianshun Biotechnology |
| 16:30-16:50 | Applications of Gene Editing in the Treatment of Human Diseases | Fang Riguo | R&D Director, Edigene |
| 16:50-17:10 | The Secrets in Saliva: The Future of Genetic Data (Proposed) | Chen Gang | CEO of WeGene |
| 17:10-17:30 | Current Status and Existing Issues of Immunotherapy for Gastrointestinal Tumors | Lu Zhihao | Associate Chief Physician, Department of Medical Oncology (Gastrointestinal), Beijing Cancer Hospital |
Conference Highlights:
1. Precision Investment: Current Status and Directions in Innovative Oncology Drug Investment;
2. R&D Innovation: The Current State of New Drug Development in China from a Global Perspective;
3. Clinical Transformation: New Trends in the Clinical Development and Registration of Novel Oncology Drugs in China;
4. Successful Market Launch: A Rising Star in the Rapidly Advancing Field of Innovative Oncology Drug Development.
| Time | Subject | Guest |
| 9:00-9:20 | Trends and Future of Innovative Drug Development | Hong Tan / Managing Director, Legend Capital |
| 9:20-9:40 | Global Opportunities in Investment in Innovative Oncology Drugs | Managing Partner, Zhangjiang/Ping An Venture Capital |
| 9:40-10:30 | Focus Roundtable: Investment Hotspots in Innovative Oncology Drugs | Moderator: Liu Qian / Vice President, AstraZeneca Greater China |
| Managing Partner, Zhangjiang/Ping An Ventures | ||
| Liang Zhanchao | Founding Partner, Mifang Capital | ||
| Yang Kun | Partner at DT Capital Partners | ||
| Tang Aimin | Partner at Panlin Capital | ||
| Daqing Cai | Managing Partner, Sherpa Capital | ||
| 10:30-10:50 | Clinical Development Strategies for Novel Oncology Drugs in China | Wang Yu | Partner, Xiangyan (Shanghai) Business Information Consulting |
| 10:50-11:10 | China Registration Strategy for Novel Oncology Drugs | Mao Li | Senior Vice President and Chief Medical Officer, Betta Pharmaceuticals |
| 11:10-11:30 | Development Strategies for Fully Human Antibodies | Zhou Sixiang | Head of Business Development, Greater China, Harbour BioMed |
| 11:30-12:00 | Focus Roundtable: The Path of Innovative Oncology Drug R&D in China | Host: Zhao Bei | Fund Manager at ICBC Credit Suisse Asset Management |
| Mao Li | Senior Vice President and Chief Medical Officer, Betta Pharmaceuticals | ||
| Wang Yu | Partner, Xiangyan (Shanghai) Business Information Consulting | ||
| Zhou Sixiang | Head of Business Development, Greater China, Harbour BioMed | ||
| Yang Dajun | Chairman of Ascentage Pharma | ||
| 14:00-14:20 | New Rules for the Market Launch of Antineoplastic Drugs in China | Wang Jue/Founder of Liangyi Hui Oncology Insights |
| 14:20-14:40 | The Best Opportunities for Successful R&D and Commercialization of Medical Products in China | Yi Liang / Chief Business Officer and President, Greater China, Zai Lab |
| 14:40-15:00 | Opportunities and Challenges in China's Tumor Immunotherapy Market | Mou Yanping / General Manager, MSD Oncology Business Unit |
| 15:00-15:20 | Opportunities in China for Domestically Developed Innovative Oncology Drugs | Liu Min / Chief Commercial Officer, Innovent |
| 15:30-15:50 | The Path to Market Approval for Innovative Oncology Drugs in China | Wan Jiang | Director and Senior Vice President of Betta Pharmaceuticals |
| 15:50-16:30 | Spotlight Roundtable: Market/Medical Executives from Successfully Listed Innovative Pharmaceutical Companies | Moderator: Liu Qian, Vice President of AstraZeneca Greater China |
| Wang Jue / Founder of Liangyi Hui Oncology Insights | ||
| Wan Jiang | Director and Senior Vice President, Beta Pharma | ||
| Yanping Mu / General Manager, MSD Oncology Business Unit | ||
| Liang Yi / Chief Business Officer and President, Greater China, Zai Lab |
Conference ViewDot:Specially inviting leading companies in the healthcare sector to gather and jointly explore and uncover the "unicorn" DNA.。
| Time | Subject | Guest |
| Host: Bi Yuanfeng | Co-founder and COO of VCBeat | ||
| 9:00-9:20 | From 0 to 1: AnHan Medical’s Path to Unicorn Status | Huan Dandan | Vice President of Anhan Medical |
| 9:20-9:40 | AI-Empowered Medical Big Data | Fang Cong | Vice President, Infervision |
| 9:40-10:00 | Industrial Innovation in the New Healthcare Ecosystem Empowered by Medical Big Data | Zhang Tianze | CEO of LinkDoc Technology |
| 10:00-10:20 | Reflections on AI-Driven Healthcare Application Scenarios (Draft) | Tu Zhiliang | Chairman and President of Gushengtang |
| 10:20-10:40 | Technological Innovation and Industry Growth Trajectory in Gene Sequencing | Sun Lele | Head of Mingma Biological Laboratory |
| 10:40-11:00 | Operations Management of Chain Oncology Hospitals | Ren Ai | Board Secretary and Investment Director of Hygeia |
| 11:00-12:00 | Focus Roundtable: The “New Posture” of China’s Healthcare Unicorns | Moderator: Zhou Jun | Partner, Kunyuan Assets |
| Jiang Xiaodong | Managing Partner, Changling Capital | ||
| Yang Yunxia | Managing Director, Sequoia Capital | ||
| Wang Jianfei | Managing Director, Legend Capital | ||
| Wu Kai | Partner, SoftBank China | ||
| Xu Qian | Partner, DT Capital Partners | ||
Conference Highlights:
1. In-depth Study of the Domestic Specialty Chain Business Model;
2. Shared Chain Clinics, how can private specialized hospitals in fields such as oncology, stomatology, psychology, and rehabilitation leverage technology and capital to accelerate their development?
| Time | Subject | Guest |
| Moderator: Dong Mifang | Partner at Zhongwei Fund | ||
| 09:00-09:20 | Innovative Operational Exploration of Shared Chain Clinics | Martin | President of Penguin Almond |
| 09:20-09:40 | How to Build a Pediatric Specialty Brick-and-Mortar Hospital + Internet? | Sun Xuding | Executive Director of Beijing Jingdu Children's Hospital and Dean of its Internet Hospital |
| 09:40-10:00 | Empowering Physicians to Build a New Standardized Clinic | Sun Yan | CEO of Happy Dental |
| 10:00-10:20 | Community-Based Pain Specialty Clinic Chain | Dang Jingdong | Founder of Hepu Medical |
| 10:20-10:40 | Reflections on Replicating Specialty Clinics Amid a Capital Winter | Kang Shaoyong | President, Hongdao Medical |
| 10:40-11:00 | Discipline Construction of Minimally Invasive Surgery in Traditional Chinese Medicine Orthopedics and Traumatology + Future Development | Xue Xipeng | Founder of Qinglai Health |
| 11:00-11:20 | Speech Rehabilitation Field: A Comparison of Talent Training Systems and Methods Between China and Foreign Countries | Cui Guangli | Founder of OA Speech |
| 11:20-11:40 | Exploration of Management in Chain Psychiatric Hospitals Based on Culture | Yang Yi | Founder and CEO of Anken Medical |
| 11:40-12:00 | Reflections on Clinic Operations Centered on Primary Care | Yan Honghui | Founder of BoHou Medical |
Conference Highlights:Conduct an in-depth, forward-looking analysis of the potential demand for medical big data applications based on specific scenarios, and explore implementation pathways and investment prospects for medical big data;
| Time | Subject | Guest |
| Moderator: Wang Xiaocen | Partner, CEC Health Industry Fund | ||
| 9:00-9:20 | Domestic Policies and Progress in Health Big Data and the Transformation of Future Healthcare Services | Song Xin | President of the Medical and Health Industry Branch of the China Information Association, Secretary-General of the Professional Committee on Big Data and Artificial Intelligence for Maternal and Child Health, China Association of Maternal and Child Health |
| 9:20-9:40 | Innovation in Chronic Disease Management in the Era of Big Data | Kuang Ming | Founder and CEO of Zhiyun Health |
| 9:40-10:00 | Applications of Artificial Intelligence and Big Data Technologies in Real-World Studies | Liu Liyu | CEO of Life Singularity |
| 10:00-10:20 | Networked, Data-Driven, and Intelligent Precision Medicine | Li Xiarong | CEO of Judao Technology |
| 10:20-10:40 | The Information Superhighway Accelerating New Drug R&D | Zhao Lu | CEO of Taimei Medical Technology |
| 10:40-11:00 | The Important Role of Physician Communities in the Field of Medical Big Data | Lu Xiuling | VP, Zechuang Tiancheng |
| 11:00-11:20 | From Functionality to Intelligence: The Transformation of the Electronic Medical Record Industry and Its Investment Logic | Yu Jurong | Partner at Qingke Medical |
| 11:20-12:00 | Roundtable Focus: How Can the Application of Healthcare Big Data Be Accelerated? | Moderator: Jiang Yanye | Partner at Honghui Capital |
| Zhao Lu | Founder of Taimei Medical Technology | ||
| Liu Liyu | CEO of Life Singularity | ||
| Lu Xiuling | VP, Zechuang Tiancheng | ||
| Li Xiarong | CEO of Judao Technology | ||
| Kuang Ming | Founder and CEO of Zhiyun Health | ||
Conference Highlights:
1. Analysis of the Business Models of Health Management Companies from an Investment Perspective;
2. Innovative pathways for technical service-oriented, TCM and nutritional conditioning-oriented, and resource integration-oriented health management models;
3. What are the feasible pathways for the transformation and upgrading of health management enterprises? How should companies make their selections?
| Time | Subject | Guest |
| Moderator: Zhou Xuan | Vice President of Investment, IDG Capital | ||
| 14:00-14:20 | Current Status and Development Trends of Medical Devices in the Health Management Industry | Guan Yan | Secretary-General of the Smart and Mobile Healthcare Branch, China Association for Medical Device Industry |
| 14:20-14:40 | 2018 Unhealthy Dictionary | Kong Fei | CEO of Miao Health |
| 14:40-15:00 | Intelligent Psychiatry and Mental Health Medicine Based on Machine Learning | Ji Jun | Founder and CEO of Wanling Pangu |
| 15:00-15:20 | Building a New Model of Health Management with Traditional Chinese Medicine Conditioning | Sun Jinzheng | Founder of Yisheng Daojia |
| 15:20-15:40 | Innovative Development of Professional Medical Nutrition Services | Chen Yuxin | Founder and CEO of Yingkang Technology |
| 15:40-16:00 | Innovative Models of Community Health Management Services | Zhang Peng | Founder of Jiayou Health |
| 16:00-16:20 | New Model of Health Management | Zheng Yufen | Founding Partner and CEO of Yueyin Medical Fund |
| 16:20-17:00 | Focus Roundtable: Profit Models and Development Prospects of Health Management Enterprises from Investment and Corporate Perspectives | Host: Li Sirui | General Manager, Strategic Development Center, Tasly Holding Group |
| Zeng Mingfa | Chairman of Kangkang Blood Pressure | ||
| Li Xiaoxia | Founder of Kang Bairui | ||
| Yuan Binwen | General Manager of Dongze Special Medical Food | ||
| Xu Jianqun | Founder and CEO of 7+1 Medical Center | ||
Conference Highlights:
1. Interpretation of Intelligent Imaging Standards and Their Development Trends;
2. Development and Application of AI-Based Radiomics;
3. Applications of Big Data in Medical Imaging;
| Time | Subject | Guest |
| Host: Shi Chengxi | Vice President of Investment, Changling Capital | ||
| 14:00-14:20 | Exploration of Intelligent Healthcare Based on Deep Learning | Zhong Xin | Founder and CEO of Tumor Deepwise |
| 14:20-14:40 | Opportunities and Challenges in Medical Imaging in the Era of Artificial Intelligence and Big Data | Guo Na | Co-founder of Huiyi Huiying |
| 14:40-15:00 | The Role of Artificial Intelligence in Visual Computing and Medicine | Ding Xiaowei | CEO of Voxel Technology |
| 15:00-15:20 | From R&D to Commercialization: AI Technology in Medical Imaging | Song Jie | Founder and CEO of Xishi Yigou |
| 15:20-15:40 | Medical Imaging Medical Consortium Development and Artificial Intelligence in Medical Imaging | Gao Yunlong | Partner, Yizhan Medical Group |
| 15:40-16:00 | Cloud Intelligence Drives the Future of Healthcare | |
| 16:00-16:20 | Exploration and Practice of Third-Party Medical Imaging | Ning Ke | Senior Vice President and Chief Medical Officer of Yimai Yangguang Group |
| 16:40-17:00 | Focus Roundtable: Early Screening or Diagnosis—Where Should AI Companies Focus Their Implementation Efforts? | Moderator: Shi Chengxi | Vice President of Investment, Changling Capital |
| Zhong Xin | Founder of TumorDeep | ||
| Guo Na | Co-founder of Huiyi Huiying | ||
| Ding Xiaowei | CEO of Voxel Technology | ||
| Song Jie | Founder and CEO of Xishi Yigou | ||
| Gao Yunlong | Partner at Yizhan Technology | ||
Conference Highlights:
1. Innovations and Challenges in Third-Party Testing Services;
2. Review the development paths and future trends of third-party medical testing institutions in areas such as pathological diagnosis, nephrology, medical imaging, rehabilitation, and intelligent laboratory platforms;
| Time | Topic | Guest |
| Moderator: Zhang Chen | Partner at Probe Capital | ||
| 14:00-14:20 | Advances in the Clinical Application of Pathological Testing Technologies (Draft) | Song Zhigang | Deputy Director, Department of Pathology, Chinese PLA General Hospital |
| 14:20-14:40 | Innovation and Challenges in Third-Party Testing Services (Draft) | Jiang Ying | General Manager, Ping An Health (Testing) Center |
| 14:40-15:00 | Collaborative Work Platform and Management between Third-Party Sterile Supply Centers and Healthcare Institutions | Xu Jing | General Manager, Julikang |
| 15:00-15:20 | AI + Cloud Diagnostics: Revolutionizing and Innovating Tumor Cell Diagnosis | Sun Xiaorong | Chairman of Wuhan Landing Medical |
| 15:20-15:40 | From Hemodialysis Centers to a Full-Cycle Kidney Disease Platform: An Exploration | Gao Xing | President, Aishen Medical |
| 15:40-16:00 | Current Status and Development of Cardiac Rehabilitation in China | Lu Ji'en | CEO of Ruihua Xinkang |
| 16:00-16:20 | Discussion on Intelligent Comprehensive Oncology Solutions | Song Qing | CEO, Puti Medical |
| 16:20-16:40 | Third-Party Medical Imaging—How to Effectively Unlock Service Capacity | Sun Zhaochang | Chairman, Kaipu Imaging |
| 16:40-17:00 | Business Models and Growth Drivers of Third-Party Services | Guo Yixin | Vice President of Investment, Haoyue Capital |
We live in a grand era of exploring the “trends” shaping the future of healthcare, documenting the dynamic and transformative evolution within the health sector. We anticipate new technological breakthroughs and innovations, as well as novel models of exploration and improvement, to bring hope for life under the natural law of survival of the fittest.
December 18-19, 2018: VCBeat cordially invites you to join us in exploring the future of healthcare.
To facilitate attendees’ accommodation during the conference, the officially designated partner hotel is the Renaissance Beijing Capital Hotel (five-star). Surrounded by high-end commercial buildings and adjacent to the China World Trade Center business district and the new CCTV Headquarters, the hotel enjoys highly convenient transportation access. The guest rooms are luxuriously and elegantly decorated. The hotel also features the Yi Yi Fang restaurant and an Italian restaurant with exotic flair. Two lobby bars, The Lounge and R Lounge, along with the Spring Spa, 24-hour sauna, and indoor swimming pool, provide ideal options for relaxation and rejuvenation. Reservations are welcome.https://event.3188.la/Hotel/selectHotel?eventId=1525863138&step=0
Official Rate: Standard Room/Twin Bed, 1456/Double Breakfast
Top 100 Partnership Agreement Rate: 1,000/Double Breakfast
